Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Au-TMP Plus Radiotherapy and Toripalimab in Advanced Melanoma
NCT07562841Phase 1Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Modality
- Peptides, Nanoparticles
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Au-TMP in melanoma, sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of Dose-Limiting Toxicities. Started Apr 2026; status: recruiting.
02
Drugs
Au-TMP
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT07562841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07562841.